Canopy Growth Corp CGC

Canopy Growth is a diversified cannabis, hemp and cannabis device company with dedicated brands and cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices. The company also operates through Canopy Growth’s subsidiary, Storz & Bickel GMbH & Co. KG.

Canopy Growth’s medical division, Spectrum Therapeutics, is dedicated to education, IP development and research, furthering the public’s understanding of the cannabis field. Spectrum Therapeutics also sells a range of full-spectrum related products under the brand, Bionorica Ethics.

Canopy Growth operates in over a dozen countries across five continents. It operates retail stores across Canada under the Tweed and Tokyo Smoke banners. Canopy Growth also operates eleven licensed cannabis production sites with over 4.7 million square feet of production capacity and over one million square feet of GMP certified production space.

The company is publicly listed on the Toronto and New York Stock Exchanges. In 2019, Canopy Growth achieved annual net revenue growth of 191% to $226.3 million. That same year, the company received a new licence from Health Canada permitting it to grow cannabis at an outdoor site in northern Saskatchewan. Follow and trade CGC for more news and updates.